SCHEMBL1148198

SCHEMBL1148198

CCOC(=O)C(C)(COc1ccc(OCC)cc1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.48
▸ ABCB11 O95342 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ HTR2A P28223 1/20 0.48
▸ PMP22 Q01453 1/20 0.48
▸ PPARA Q07869 1/20 0.48
▸ MMP8 P22894 1/20 0.44
▸ NQO1 P15559 1/20 0.44
▸ PARP10 Q53GL7 1/20 0.44
▸ POLB P06746 2/20 0.43
▸ PLA2G4B P0C869 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ NPC1 O15118 2/20 0.41
▸ PLK1 P53350 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1148203 0.89 NQO1 (0.52) CYP1A2NQO1PARP10POLBPLA2G4B
SCHEMBL1148193 0.79 KMT2A (0.49) CYP1A2NQO1PARP10POLBALDH1A1
SCHEMBL1148156 0.78 TSHR (0.51) CYP1A2ABCB11CYP3A4TSHRHTR2A
SCHEMBL16568748 0.76 PLK1 (0.49) CYP1A2ABCB11CYP3A4TSHRHTR2A
SCHEMBL21991896 0.75 ALDH1A1 (0.45) CYP1A2ABCB11CYP3A4TSHRHTR2A
SCHEMBL23605682 0.74 MEN1 (0.49) CYP1A2ABCB11CYP3A4TSHRHTR2A
SCHEMBL12859831 0.74 PPARA (0.49) CYP1A2ABCB11CYP3A4TSHRHTR2A
SCHEMBL1148134 0.73 PPARA (0.56) CYP1A2ABCB11CYP3A4TSHRHTR2A
SCHEMBL21991889 0.73 ALDH1A1 (0.48) CYP1A2ABCB11CYP3A4TSHRHTR2A
SCHEMBL21991541 0.72 PPARA (0.63) CYP1A2ABCB11CYP3A4TSHRHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7884103-B2 such as N-(4-Chloro-phenyl)-2-methyl-2-phenylmethanesulfonylamino-3-(4-[1,2,4]triazol-1-yl-phenoxy)-propionamide, used for controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi SYNGENTA CROP PROTECTION, INC. (US) 2011-02-08 — — US disclosed
US-20070155748-A1 N-sulfonyl-alpha-amino-acid derivatives SYNGENTA CROP PROTECTION, INC. 2007-07-05 — — US disclosed
EP-1660441-A2 N-SULFONYL-ALPHA-AMINO-ACID DERIVATIVES Syngenta Participations AG (CH) 2006-05-31 — — EP disclosed
WO-2005021490-A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2005-03-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155748-A1 N-sulfonyl-alpha-amino-acid derivatives C3AR1, GLRA1, C5AR1 CYP1A2 838/4885ABCB11 1814/4885CYP3A4 1030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback